MK Hamied has resigned as Vice Chairman with effect from October 29 due to age and health, according to a statement released by drug company Cipla on Tuesday.
He wrote to the board of directors, saying, “It is with a heavy heart that I write to formally announce my resignation from the position of Vice Chairman and Non-Executive Director of the company.”
According to the corporation, Kamil Hamied’s appointment as a non-executive director, effective November 1, 2024, has also been accepted by the board.
“I am pleased to see that Kamil Hamied will be joining the Board as a Non-Executive Director to maintain continuity while representing the promoter family,” MK Hamied wrote in the letter.